Genomic Pathway Approach to Parkinson Disease
Author Information
Author(s): Lesnick Timothy G, Papapetropoulos Spiridon, Mash Deborah C, Ffrench-Mullen Jarlath, Shehadeh Lina, de Andrade Mariza, Henley John R, Rocca Walter A, Ahlskog J. Eric, Maraganore Demetrius M
Primary Institution: Mayo Clinic College of Medicine
Hypothesis
Does polymorphism in the axon guidance pathway predispose individuals to Parkinson disease?
Conclusion
The study found that multiple SNPs in axon-guidance pathway genes are strong predictors of Parkinson disease susceptibility, survival free of the disease, and age at onset.
Supporting Evidence
- Models constructed from axon guidance SNPs predicted PD susceptibility with an odds ratio of 90.8.
- Models predicted survival free of PD with a hazards ratio of 19.0.
- Models predicted age at onset of PD with an R² of 0.68.
- Findings were validated using a second whole-genome association dataset.
- Many axon-guidance pathway genes were differentially expressed in PD cases compared to controls.
Takeaway
This study shows that certain genes involved in guiding brain connections can affect the risk and timing of developing Parkinson's disease.
Methodology
The study used bioinformatic methods to mine a whole-genome association dataset for SNPs within axon-guidance pathway genes and constructed predictive models for PD outcomes.
Potential Biases
Potential biases due to sample size and multiple tested relationships.
Limitations
The findings have not been replicated with identical SNPs in independent samples.
Participant Demographics
Median age at onset of PD among cases was 61 years, with a range from 31 to 94 years.
Statistical Information
P-Value
4.64 × 10−38
Confidence Interval
95% CI 6.94 × 10−28 − 5.39 × 10−40
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website